Adherence to Clinical Surveillance Guidelines in von Hippel-Lindau (vHL) disease: Evaluating the impact of a Coordinated Care Centre Implementation in Canada
Dr Xin (Cynthia) Ye
A Retrospective Study Demonstrating Higher Completion Rates of Parallel Germline Testing vs Sequential Ordering After Tumor BRCA1/2 Mutation Detection
Dr. Heather Halperin
Analysis of Young Onset Colorectal Cancer (YOCRC): Implications for Research and Clinical Practice
Dr. Graydon Arthur
Characterizing BRCA1/2-Mutated Advanced Non-Small Cell Lung Cancer (NSCLC): Clinical Features, Outcomes, and Germline Testing Patterns
Dr. Patsy Lee
Impact of Time of Infusion of Immunotherapy on Efficacy in Metastatic Urothelia Cancer
Dr. Sarah Yeo
Incidence of Chronic Immune Related Adverse Events (irAEs) in patients with advanced Melanoma Treated with immune Checkpoint Inhibitors in British Columbia
Dr. Erin McAndrew
Optimizing Oral Anticancer Drug Prescribing and Dispensing at BC Cancer Vancouver Centre: First Month Audit Results of a Quality Improvement Study
Dr. Hyejee Ohm
PANNTHR: A Phase I Study of Abemaciclib and Niraparib as Neoadjuvant Therapy in HR+HER2 Breast Cancer
Dr. Faisal Alsadoun
Real World Outcomes and Toxicity with Belzutifan in the Treatment of Von Hippel–Lindau Disease a Single Centre Canadian Experience
Dr. Chloe Lim
Real World Efficacy and Outcomes in older Adults with Advanced Anaplastic Lymphoma Kinase (ALK) – A Canadian Multicenter Experience
Dr. Andrew Jamroz
Updated Outcomes in Hodgkin Variant Richter Transformation in Chronic Lymphocytic Leukemia and small Lymphocytic Lymphoma in British Columbia